{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:52:52Z","timestamp":1789980772078,"version":"4.0.1"},"reference-count":60,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2010,6,30]]},"DOI":"10.2217\/fon.10.71","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T10:28:19Z","timestamp":1275992899000},"page":"885-891","source":"Crossref","is-referenced-by-count":43,"title":["Salirasib in the Treatment of Pancreatic Cancer"],"prefix":"10.1080","volume":"6","author":[{"given":"Ernesto","family":"Bustinza-Linares","sequence":"first","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX77030, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX77030, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolia-Maria","family":"Tsimberidou","sequence":"additional","affiliation":[{"name":"Department of Investigational Cancer Therapeutics, The Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX77030, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,6,8]]},"reference":[{"key":"e_1_3_2_3_1_1","volume-title":"World Cancer Report","author":"Boyle P","year":"2008","unstructured":"Boyle P , LevinB (Eds): World Cancer Report. WHO International agency for research on Cancer, Lyon, France (2008)."},{"key":"e_1_3_2_3_2_1","volume-title":"Cancer Facts and Figures","author":"American Cancer Society","year":"2009","unstructured":"American Cancer Society : Cancer Facts and Figures. American Cancer Society, GA, USA (2009)."},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdl498"},{"key":"e_1_3_2_3_4_1","volume-title":"Pocket Medicine: Pancreatic Cancer (3rd Edition)","author":"Sabatine MS","year":"2008","unstructured":"Sabatine MS : Pocket Medicine: Pancreatic Cancer (3rd Edition). Lippincott Williams & Wilkins, PA, USA (2008)."},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850715)56:2<397::AID-CNCR2820560232>3.0.CO;2-I"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365529209000081"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.17.954"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.3.267"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605256"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.23.911"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2403"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.62.070193.004223"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.16.4848"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/2041104b0"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"crossref","unstructured":"Kirsten WH SchaufV McCoyJ: Properties of a murine sarcoma virus.Bibl. Haematol. (36) 246\u2013249 (1970).","DOI":"10.1159\/000391714"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01660"},{"key":"e_1_3_2_3_17_1","volume-title":"Robbins and Cotran Pathologic Basis of Disease (Professional Edition)","author":"Kumar V","year":"2010","unstructured":"Kumar V , AbbasA, FaustoNet al.: Robbins and Cotran Pathologic Basis of Disease (Professional Edition). Saunders, PA, USA (2010)."},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10109"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)35739-9"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.4-3-263"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2008.03.008"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(99)00071-X"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204950"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(00)01789-5"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.10.112"},{"key":"e_1_3_2_3_26_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8316833"},{"key":"e_1_3_2_3_27_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.8316834"},{"key":"e_1_3_2_3_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312697200"},{"key":"e_1_3_2_3_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncb1615"},{"key":"e_1_3_2_3_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(07)00432-6"},{"key":"e_1_3_2_3_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2005.04.020"},{"key":"e_1_3_2_3_32_1","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20050231"},{"key":"e_1_3_2_3_33_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200209091"},{"key":"e_1_3_2_3_34_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.14.8.895"},{"key":"e_1_3_2_3_35_1","doi-asserted-by":"publisher","DOI":"10.1042\/BST0330657"},{"key":"e_1_3_2_3_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrm1105"},{"key":"e_1_3_2_3_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0451-6"},{"key":"e_1_3_2_3_38_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi972032d"},{"key":"e_1_3_2_3_39_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.24.14019"},{"key":"e_1_3_2_3_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4889(99)00144-5"},{"key":"e_1_3_2_3_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm00008a004"},{"key":"e_1_3_2_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2004.04.004"},{"key":"e_1_3_2_3_43_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.3.1606"},{"key":"e_1_3_2_3_44_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-4287"},{"key":"e_1_3_2_3_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21222"},{"key":"e_1_3_2_3_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cad.0000185184.64980.39"},{"key":"e_1_3_2_3_47_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03402049"},{"key":"e_1_3_2_3_48_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.999.65.3"},{"key":"e_1_3_2_3_49_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0792"},{"key":"e_1_3_2_3_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s001099900052"},{"key":"e_1_3_2_3_51_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2003.12009.x"},{"key":"e_1_3_2_3_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-00009577-200602001-00032"},{"key":"e_1_3_2_3_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.05.007"},{"key":"e_1_3_2_3_54_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202602"},{"key":"e_1_3_2_3_55_1","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.4626","article-title":"Integrated development of S-trans,trans-farnesylthiosalicyclic acid (FTS, salisarib) in pancreatic cancer.","volume":"26","author":"Rudek MA","year":"2008","unstructured":"Rudek MA , KhanH, GoldsweigHet al.: Integrated development of S-trans,trans-farnesylthiosalicyclic acid (FTS, salisarib) in pancreatic cancer.J. Clin. Oncol.26(Suppl.) (2008) (Abstract 4626).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_3_56_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-1027-4"},{"issue":"15","key":"e_1_3_2_3_57_1","article-title":"Integrated development of S-trans, trans-farnesylthiosalicyclic acid (FTS, salirasib) in advanced pancreatic cancer.","volume":"27","author":"Laheru D","year":"2009","unstructured":"Laheru D , RudekM, TaylorGet al.: Integrated development of S-trans, trans-farnesylthiosalicyclic acid (FTS, salirasib) in advanced pancreatic cancer.J. Clin. Oncol.27(Suppl. 15) (2009) (Abstract 4529).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_3_58_1","article-title":"Phase I first-in human study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.","volume":"26","author":"Tsimberidou A-M","year":"2008","unstructured":"Tsimberidou A-M , RudekMA, HongDSet al.: Phase I first-in human study of S-trans,trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors.J. Clin. Oncol.26(Suppl.) (2008) (Abstract 3536).","journal-title":"J. Clin. Oncol."},{"key":"e_1_3_2_4_2_1","unstructured":"US NIH: National Cancer Institute drug dictionary www.cancer.gov\/drugdictionary\/?CdrID=573226"},{"key":"e_1_3_2_4_3_1","unstructured":"National Cancer Institute thesaurus http:\/\/ncit.nci.nih.gov\/ncitbrowser\/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C71146"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.10.71","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:24Z","timestamp":1719124944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.10.71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,8]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6,30]]}},"alternative-id":["10.2217\/fon.10.71"],"URL":"https:\/\/doi.org\/10.2217\/fon.10.71","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,8]]}}}